Skip to main content
. 2014 Nov 10;6(6):1759091414558417. doi: 10.1177/1759091414558417

Figure 3.

Figure 3.

Representative images of BrdU and DCX double immunofluorescence staining 7 days after ischemia. The pictures were from the rats in control group (a–c), edaravone-treated group (d–f), and sham-operated group (g–i). BrdU immunoreactivity (green). DCX immunoreactivity (red). Arrows indicated BrdU/DCX-double-positive cells. BrdU = 5-Bromo-2-deoxyuridine; DCX = doublecortin. Scale bar = 50 µm.